Dr Molly Jeffery, of the Mayo Clinic in Minnesota, details a practice that may be undermining patients’ decision-making regarding whether or not to visit emergency care, and discusses her research on a potential solution. For more, visit www.consultant360.com.

Dr Molly Jeffery, of the Mayo Clinic in Minnesota, details a practice that may be undermining patients’ decision-making regarding whether or not to visit emergency care, and discusses her research on a potential solution. For more, visit www.consultant360.com.

In part 2 of this series, board-certified nurse practitioner Lucia Novak, director of Riverside Diabetes Center, discusses the benefits of long-acting insulins and barriers that may prevent more widespread implementation of these therapies. For more, visit www.consultant360.com.

In part 2 of this series, board-certified nurse practitioner Lucia Novak, director of Riverside Diabetes Center, discusses the benefits of long-acting insulins and barriers that may prevent more widespread implementation of these therapies. For more, visit www.consultant360.com.

In part 2 of this series, board-certified nurse practitioner Lucia Novak, director of Riverside Diabetes Center, discusses the benefits of long-acting insulins and barriers that may prevent more widespread implementation of these therapies. For more, visit www.consultant360.com.

Dr Maria Suarez-Almazor discusses the prevalence of patient nonadherence to medications in a rheumatology setting, how a provider can improve their patient/provider relationship, and more.

Dr Maria Suarez-Almazor discusses the prevalence of patient nonadherence to medications in a rheumatology setting, how a provider can improve their patient/provider relationship, and more.

Dr Maria Suarez-Almazor discusses the prevalence of patient nonadherence to medications in a rheumatology setting, how a provider can improve their patient/provider relationship, and more.

Dr Stephen Kopecky from Mayo Clinic talks about nonpharmacologic and pharmacologic options for preventing atrial fibrillation.

Dr Stephen Kopecky from Mayo Clinic talks about nonpharmacologic and pharmacologic options for preventing atrial fibrillation.